Hypoxia inducible factor-1α in human emphysema lung tissue

European Respiratory Journal

Volumn 37, Issue 4, 2011, Pages 775-783

  Yasuo, M ^a   Mizuno, S ^a   Kraskauskas, D ^a   Bogaard, H J ^a   Natarajan, R ^a   Cool, C D ^b   Zamora, M ^b   Voelkel, N F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Hypoxia inducible factor 1 ; Vascular endothelial growth factor

Indexed keywords

CORTICOSTEROID; HISTONE DEACETYLASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ENDOTHELIUM; LUNG PARENCHYMA; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; CELL NUCLEUS; COHORT STUDIES; CYTOPLASM; EMPHYSEMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79851481837     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00022910     Document Type: Article

References (48)

1. Kim WD, Ling SH, Coxson HO, et al. The association between small airway obstruction and emphysema phenotypes in COPD. Chest 2007; 131: 1372-1378. (Pubitemid 46762341)
2. Baldi S, Miniati M, Bellina CR, et al. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 585-589. (Pubitemid 32801661)
3. Kim WD, Eidelman DH, Izquierdo JL, et al. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis 1991; 144: 1385-1390.
4. Finkelstein R, Fraser RS, Ghezzo H, et al. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666-1672. (Pubitemid 3002087)
5. Sullivan AK, Simonian PL, Falta MT, et al. Oligoclonal CD4+ T-cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005; 172: 590-596. (Pubitemid 41232970)
6. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87: 1047-1082. (Pubitemid 47084676)
7. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008; 118: 394-402. (Pubitemid 351206526)
8. Tuder RM, Petrache I, Elias JA, et al. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003; 28: 551-554. (Pubitemid 36543401)
9. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290: L209-L221.
10. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-744. (Pubitemid 32230838)
11. Suzuki M, Betsuyaku T, Nagai K, et al. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol 2008; 20: 349-359. (Pubitemid 351323659)
12. Mueller MD, Vigne JL, Minchenko A, et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 2000; 97: 10972-10977.
13. Jung YJ, Isaacs JS, Lee S, et al. IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 17: 2115-2117.
14. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 306: re12.
15. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009; 24: 97-106.
16. Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008; 453: 807-811. (Pubitemid 351793778)
17. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-26771.
18. Haddad JJ. Recombinant human interleukin (IL)-1 β-mediated regulation of hypoxia-inducible factor-1 α (HIF-1 α) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw 2002; 13: 250-260.
19. Stevens T, Kasper M, Cool C, et al. Pulmonary circulation and pulmonary hypertention. In: Aird WC, ed. Endothelial Cells on Health and Disease 3rd Edn. Boca Raton Florida, Taylor Francis, 2005; pp. 417-438.
20. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311-1319.
21. Tang K, Rossiter HB, Wagner PD, et al. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004; 97: 1559-1566. (Pubitemid 39299378)
22. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174: 886-893. (Pubitemid 44564788)
23. Sutton TA, Wilkinson J, Mang HE, et al. p53 regulates renal expression of HIF-1α and pVHL under physiological conditions and after ischemia-reperfusion injury. Am J Physiol Renal Physiol 2008; 295: F1666-F1677.
24. Yang J, Ahmed A, Poon E, et al. Small-molecule activation of p53 blocks hypoxia-inducible factor 1α and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia. Mol Cell Biol 2009; 29: 2243-2253.
25. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490. (Pubitemid 28373960)
26. Groenman F, Rutter M, Caniggia I, et al. Hypoxia-inducible factors in the first trimester human lung. J Histochem Cytochem 2007; 55: 355-363. (Pubitemid 46481943)
27. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352: 1967-1976. (Pubitemid 40638367)
28. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
29. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 50-60. (Pubitemid 40562963)
30. Tuder RM, Yoshida T, Arap W, et al. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006; 3: 503-510.
31. Semenza GL. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2005; 2: 68-70. (Pubitemid 40562965)
32. Semenza GL. Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 2006; 10: 267-280.
33. Granger A, Abdullah I, Huebner F, et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 2008; 22: 3549-3560.
34. Natarajan R, Salloum FN, Fisher BJ, et al. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium. Am J Physiol Heart Circ Physiol 2007; 293: H1571-H1580. (Pubitemid 47367202)
35. Grover TR, Asikainen TM, Kinsella JP, et al. Hypoxia-inducible factors HIF-1α and HIF-2α are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1345-L1351. (Pubitemid 47077351)
36. Klekamp JG, Jarzecka K, Perkett EA. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol 1999; 154: 823-831. (Pubitemid 29122601)
37. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008; 6: 351-374.
38. Deslee G, Woods JC, Moore C, et al. Oxidative damage to nucleic acids in severe emphysema. Chest 2009; 135: 965-974.
39. Ziel KA, Grishko V, Campbell CC, et al. Oxidants in signal transduction: impact on DNA integrity and gene expression. FASEB J 2005; 19: 387-394. (Pubitemid 40316527)
40. Pastukh V, Ruchko M, Gorodnya O, et al. Sequence-specific oxidative base modifications in hypoxia-inducible genes. Free Radic Biol Med 2007; 43: 1616-1626. (Pubitemid 350122986)
41. Charron CE, Chou PC, Coutts DJ, et al. Hypoxia-inducible factor 1α induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription. J Biol Chem 2009; 284: 36047-36054.
42. Kim MS, Kwon HJ, Lee YM, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001; 7: 437-443. (Pubitemid 32298546)
43. Mizuno S, Yasuo M, Bogaard HJ, et al. HDAC inhibition causes apoptosis in human pulmonary endothelial cells and lung fibroblasts. Am J Respir Crit Care Med 2010; 181: A3455.
44. Kovacs JJ, Murphy PJ, Gaillard S, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 2005; 18: 601-607. (Pubitemid 40726236)
45. 2-independent and HSP90 inhibitor-induced degradation of HIF-1α. Mol Cell 2007; 25: 207-217.
46. Breit JF, Ault-Ziel K, Al-Mehdi AB, et al. Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter. FASEB J 2008; 22: 19-29.
47. Ruchko MV, Gorodnya OM, Pastukh VM, et al. Hypoxia-induced oxidative base modifications in the VEGF hypoxia-response element are associated with transcriptionally active nucleosomes. Free Radic Biol Med 2009; 46: 352-359.
48. Ellis L, Hammers H, Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 2009; 280: 145-153.